Observations of Respiratory Syncytial Virus(RSV) NucleicAcidsin Wastewater Solids Across the United States in the 2022−2023 Season: Relationships with RSV Infection Positivity Hospitalization Rates 
Alessandro Zulli,Meri R.J.Varkila, Julie Parsonnet, Marlene K. Wolfe, and Alexandria B.Boehm 
ABSTRACT: Respiratory syncytial virus(RSV) is a leading cause of respiratory illness and hospitalization, but clinical surveillance detects only a minority of cases. Wastewater surveillance could determine the onset and extent of RSV circulation in the absence of sensitive case detection, but to date, studies of RSV in wastewater are few. We measured RSV RNA concentrations in wastewater solids from 176 sitesduring the 2022−2023 RSV season and compared those to publicly available RSVinfection positivity and hospitalization rates. Concentrations ranged from undetectable to 107 copies per gram RSV RNA concentration aggregated at state and national levels correlated with infection  positivity and hospitalization rates. RSV season onset was determined using both wastewater and clinical positivity rates usingindependent algorithms for 14 states where both data were available at the start of the RSV season. In 4 of 14 states, wastewater and clinical surveillance identified RSV seasonon set during the same week; in 3 states,wastewater onset preceded clinical onset, and in 7 states, wastewater onset occurred after clinical onset. Wastewater concentrations generally peaked in the same week as hospitalization rates but after case positivity rates peaked. Differences in onset and peaks in wastewater versus clinical data may reflect inherent differences in the surveillance approaches. KEYWORDS:wastewater-based epidemiology, onset,epidemic pattern, respiratory syncytial virus,RSV,hospitalization rate 
INTRODUCTION Respiratory syncytial virus(RSV)is a leading cause of pediatric pneumonia and bronchiolitis and is responsible for over 100,000 pediatric deaths worldwide each year. In the US, RSV annually accounts for up to 80,000 hospitalizations over 520,000 emergency department visits in children under 5. RSV infects 97% of all children by the age of 2, making it a ubiquitous cause of acute respiratory tract infection in children and a large driver of morbidity and mortality within this cohort. RSVisalsoaconcernintheagingpopulation, responsibleforupto10,000recordedyearlydeathsinthe cohortaged65andolder.5,9 RSVtransmissiontypicallyfollowsapredictableseasonal pattern,withpeaksintheNorthernHemisphereoccurringin thelatefallandextendingthroughspring.10Pinpointingthe onsetandseverityoftheRSVseasoncouldenhanceefficient allocationofresourcestowhereandwhentheyareneededand signalpublichealthauthoritiestocampaignforimmunization. IntheUS,RSVsurveillanceisconductedthroughseveral networksthattracktemporalandgeographictrendsinclinical illnessandhospitalizations ofpatients.11Thedetermination epidemiconsetiscurrentlytiedtolaboratory-based testingofclinicalcases�ametricbasedonvoluntaryreportingthatdoes notcapturethefullmagnitudeofRSVcirculationinthe communityandispronetoreportingtimelags.12Asaresult, theannualonsetofRSVtransmissionatthecommunitylevel mayberecognizedafterithasbegun.Althoughusingclinical dataistheapproachcurrentlyavailableandusedtoassessthe startoftheRSVseason,theapproachisimperfect. DuringtheCOVID-19pandemic,manycountries,including theUS,observeddrasticreductionsinRSVinfectionsthe winterof2020−21followedbyunseasonalRSVactivityinthe summerof2021andatypicallyearlyonsetofRSVcirculation withmoresevereclinicalpresentationofdiseaseduringthe winterof2022−2023.10−13Newimmunizations became publiclyavailableinthefallof2023,aftertheendofour study,andincludeavaccineforuseduringpregnancy,along- Received:November16,2023 Revised:February13,2024 Accepted:February14,2024 Published:February29,2024 Article pubs.acs.org/estwater ©2024TheAuthors. Published American Chemical Society 1657https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−1667 This article licensed CC-BY-NC-ND 4.0 Downloaded via TEMPLE UNIV October 7, 2024 19:05:11 (UTC). See https://pubs.acs.org/sharingguidelines options legitimately share published articles.actingmonoclonalantibody(nirsevimab)recommended immunization ofinfants8monthsoldandyounger,andanew vaccineavailableforpeople60andolder.Theserecentchanges inRSVcirculationandtoolsforresponsemakethe determination oftheonsetofannualRSVepidemicsan especiallyimportant,yetdifficult,task. Wastewaterprovidesacompositebiologicalsamplefora communitythatcanbeusedtomonitorthelocaloccurrenceof infectiousdiseases.Previousstudieshavedemonstrated wastewaterconcentrations ofRSVRNAcorrelatewithdisease occurrencewithinthecommunitiescontributingtowaste- water;14−21however,thesestudieshavebeenconductedat smallgeographicscales.Wehavepreviouslydemonstrated wastewater-based measurements ofinfluenzacanberelatedto traditionalsurveillancemetricsacrosstheUS.22Inthisstudy, weusedatafromacrosstheUStoinvestigatehowRSVRNA concentrations inthesolidsfromwastewaterrelateto traditionaldiseasemetricsduringthe2022−2023RSVseason. Wealsotestthefeasibilityofusingwastewater-based estimationstodeterminetheonsetoftheRSVseason.■METHODS Weconductedaretrospectiveobservationalanalysisusingdata onRSVRNAconcentrations inwastewatercollectedaspartof thisstudyalongwithpubliclyavailableclinicalandlaboratory dataonRSVtestpositivityandhospitaladmissions.Data between1January1,2022to31July31,2023wereused.This studyanalyzedpubliclyavailableclinicaldatathatdonot containprotectedhealthinformationandwasthereforeexempt fromethicsreviewandtheneedforinformedconsentasper CommonRule45CFR46.102. ClinicalSurveillance Data.TheCDCNationalRespira- toryandEntericVirusSurveillanceSystem(NREVSS)isalaboratory-based surveillancesystemthatrecordsvoluntarily reporteddataonlaboratorytesting,includingconfirmedRSV infections,onaweeklybasisfromparticipatinglaboratories nationwide.23ThenumberofPCRtestsperformedandthe proportionofpositivePCRresultsforRSVwereextractedby thestateandatanationalleveldirectlyfromthewebsiteand areavailableforeachmorbidityandmortalityweeklyreport (MMWR)weekas3weekmovingaverages;thisproportionis referredtoas“positivityrate”.Wedidnotutilizeresultsfrom theantigentesting.Nouniversalrecommendations eligibilitycriteriaexistforaccesstoRSVclinicaltesting,and therearefrequentlygeographicandfinancialbarriersto healthcareintheUS.Asaresult,testingpracticescanvary considerablyamongstates,counties,andhealthcareproviders participatinginNREVSS. WeobtainedRSVhospitalization ratesfromtheCDC RespiratorySyncytialVirusHospitalization SurveillanceNet- work(RSV-Net),aplatformthatconductssurveillancefor laboratory-confirmed hospitaladmissionsassociatedwithRSV in12states.24Hospitalization ratedataareavailableona weeklybasis.ClinicaldataareavailableattheStanfordDigital Repository(https://purl.stanford.edu/hd388xb1982). Wastewater Data:SampleCollection.Between1 January2022and31July2023,wastewatersamples(either 24hcompositedinfluentorgrabsamplesfromtheprimary clarifier,TableS1)werecollectedbywastewatertreatment plant(WWTP)staffusingsterilecontainers.Sampleswere typicallyobtainedthreetimesperweekandshippedovernight tothelaboratoryat4°Cwheretheywereprocessed immediately.Duringthetimebetweensamplecollectionand transport(0−3days),weexpectminimallossesoftheRNA targetbasedonresultsofviralRNApersistencestudies.25 SampleswerecollectedfromWWTPsinatotalof34states Figure1.LocationofWWTPswithRSVRNAdataisincludedinthepaper.EachorangedotrepresentsthelocationofeachWWTP.ACSES&TWater pubs.acs.org/estwater Article https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−16671658overthecourseofthestudyperiodand176distinctWWTPs (Figure1).Thedatewhensamplecollectioncommenced variedbyWWTP,dependingonwhenthesamplewasenrolled inthestudy(TableS1).Atotalof22,809sampleswere collectedandanalyzedaspartofthisstudy. PreviousworkhasindicatedthatRSVRNAinwastewater stronglyadsorbstowastewatersolids,sointhisstudy,wemake measurements inthesolidphaseofwastewater.26Detailsofthe isolationofsolidsfromthesamplesareprovidedinotherpeer- reviewedpublications.27Inshort,sampleswerecentrifugedto dewaterthesolids,andanaliquotwasusedfornucleic-acid extractions,andanotherwasusedtodeterminethedryweight ofthesolids. Wastewater Data:Nucleic-Acid Extraction. The methodsfornucleicacidextractionandpurificationare providedonprotocols.io.28Inbrief,dewateredsolidswere suspendedinaDNA/RNAshield(Zymo,Irvine,CA) containingbovinecoronavirus(BCoV,anextractioncontrol). Theconcentration ofsolidsintheDNA/RNAshield approximately 75mg/mL;wefoundthatthereislimited inhibitionofdownstreamanalyticalmeasurements usingthis concentration ofsolids.27Thesuspensionwashomogenized andthencentrifuged,andnucleicacidswereextractedfrom6 to10aliquotsofthesupernatantusingacommercially availablekit(ChemagicViralDNA/RNA300KitH96, PerkinElmer, Shelton,CT).Theresultantextractswere subjectedtoinhibitorremovalusingaZymoOneStepPCR InhibitorRemovalKit(Zymo,Irvine,CA).Atotalof300μL enteredeachextractionresultingin50μLofnucleic-acid extractforeachofthereplicates.Thenumberofreplicates variedbyWWTPasindicatedinFigureS1. Wastewater Data:Analytical Methods.Concentrations ofRSV,peppermildmottlevirus(PMMoV),andBCoVRNA ineachextractweremeasuredusingdropletdigitalRT-PCR. PrimersforRSVwerepreviouslydevelopedanddetectboth RSVAandRSVB.15PMMoVisusedasawholeprocess endogenouscontrolandafecalstrengthcontrol;itisahighly abundantplantviruspresentinwastewaterglobally.29,30BCoV servedasanextractioncontrol.Primersandprobesforallof theassayswerepurchasedfromIDT(Coralville,Iowa)andare presentedinTableS2. PMMoVandBCoVweremeasuredusingaduplexassay previouslydescribedusinga1:100dilutionofthenucleic-acid extractsastemplate.27Tworeplicatewellswererunforthe PMMoV/BCoV assays,with10replicatewellsrunforasmall subsetoftheWWTPs(FigureS1).Eachofthe6−10replicate nucleic-acidextractionsobtainedfromeachsamplewasrun neatasatemplateinitsownRT-PCRwelltomeasureRSV RNAconcentrations. TheRSVassaywasruninamultiplex reactionwithassaysforothertargets;thepreciseothertargets includedvariedoverthecourseoftheprospectivestudy,as publichealthneedsandinterestschangedwithemerging outbreaksandsciencetosupporttheuseofwastewaterfora broadrangeofinfectiousdiseasetargets.Thepreciseassays thattheRSVassaywasmultiplexedwitharepresentedin FigureS1.AdditionaldetailsoftheRT-PCRassays(cycling conditions,thresholding)arepresentedintheSI.27Extraction andPCRpositiveandnegativecontrolswererunoneach96- wellplate,asdescribedelsewhere.27 Concentrations ofthetargetsarepresentedascopiesper gramofdryweight.Forasampletobescoredasapositive, therehadtobeatleastthreepositivedroplets.Thelower detectionlimitforRSVisapproximately 1000copies/gofdryweight.Errorsarereportedasstandarddeviationsonthe measurements asobtainedfromtheinstrumentsoftware, QuantaSoftAnalysisProSoftware(Bio-Rad,version1.0.596) andQXManagerSoftware(Bio-Rad,version2.0).Wastewater dataarepubliclyavailablethroughtheStanfordDigital Repository(https://purl.stanford.edu/hd388xb1982). Spatial-Aggregation ofWastewater Data.Weaggre- gateddataacrossstatesandacrossthenationusingthe followingmethods.First,state-aggregated populationweighted averageswerecalculatedforeachstatewithatleastone WWTPparticipatingintheprojectusingthefollowing equation: = * = = pop RSV/PMMoV () trimmedRS V/PMMoV() / pop S iX iX 1 1 k j j j j j jy { z z z z z zi k j j j j j jy { z z z z z z (1) whereRSV/PMMoVS(d)isthestate-aggregated population weightedaverageofRSVnormalizedbyPMMoVforstateson dayd,popiisthepopulationservedbyWWTPiofXtotalin thestate,andtrimmedRSV/PMMoV i(d)isthe5-adjacent samplecentered,trimmedaverageofRSV/PMMoV WWTPiondayd.PriortocalculatingRSV/PMMoV S(d), nondetectvaluesweresetto500cp/g(approximately halfthe limitofdetection)dividedbythePMMoVvaluefortheplant thatdayd,andvaluesfortrimmedRSV/PMMoV i(d)days withoutdatawereinterpolatedusingalinearinterpolation fromadjacentdatapoints.WealsocalculatedRSVS(d),which isanalogoustoRSV/PMMoV S(d)butusestrimmedRSV(d) ratherthantrimmedRSV/PMMoV ineq1. Weaggregateddataacrossthenationusingthefollowing equation: = * = = RSV/PMMoV () popRSV/PM MoV()/ pop N sS sS 1 1 k j j j j j jy { z z z z z zi k j j j j j jy { z z z z z z (2) whereRSV/PMMoV N(d)isthenationallyaggregatedaverage ofwastewaterconcentrations ofRSV/PMMoV asafunctionof dayd,popsisthepopulationofstatesofSstatesincludedin thestudy,andRSV/PMMoV S(d)isdefinedaboveineq1.We alsocalculatedRSVN(d)whichisanalogoustoRSV/ PMMoVN(d)butusesRSVS(d)ratherthanRSV/PMMoV S(d) ineq2. IncaseswheredatafromaspecificWWTPhadsignificant gapsbetweenobservations (21ormoredaysofno observation),thedatafromthatWWTPwerenotincluded inthestatelevelaggregationforthoseperiodsbutreincluded onceobservationsresumed. DataAnalysis: Correlations. Totestassociationsbetween wastewaterandclinicalmeasures,wecalculatedspearman’srho correlationsbetweenwastewaterconcentrations andpositivity ratesandbetweenwastewaterconcentrations andhospital- izationsforstateswherebothdatasetswereavailable.Data normalitywasassessedusingShapiro−Wilk’s methodforRSV/ PMMoVSandRSV/PMMoV Nandwerefoundtonotbe normallydistributed(allp<10−10).Therefore,anon- parametricmethodwaschosentoassesscorrelation.As clinicaldataareavailableonaweeklybasis,weusedtheweekly medianRSV/PMMoV SorRSV/PMMoV Ndependingon whetherthecorrelationsweredoneatthestateornationalACSES&TWater pubs.acs.org/estwater Article https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−16671659level,respectively.Medianswerechosenasdatawerenot- normal,butsimilarresultswereobtainedusingweeklymeans. WeeksweredefinedasbytheCDCmorbidityandmortality weeklyreport(MMWR).Weconductedatotalof44 correlationsandtoaccountformultiplecorrelationsusedap valueof0.001toidentifystatisticallysignificantcorrelationsfor alpha<0.05(0.05/44=0.001).Thisstudydidnotconsidera timeseriesregressionanalysis,duetoautocorrelation inthe timeseriesandthelowresolutionclinicaldatastreams.Future workwithhigherresolutionclinicaldataandadvancedtime seriesmethodswouldbeusefultobetterunderstandthe temporalrelationshipbetweenthetwoindicatorsofRSV. DataAnalysis: RSVSeasonCharacteristics. Theonset andoffsetoftheRSVseasonweredeterminedusingboth clinicalmetricsandwastewater.Statesforwhichwastewater datadidnotexistpriortotheclinicalonsetdateofthe2022− 2023RSVseason,asdeterminedbypositivityratedata,were excludedfromthisanalysis(FigureS2).Thisleft14statesincludedintheanalysis(CA,CO,FL,ID,IL,IN,KS,KY,MI, ME,NH,NJ,UT,andTX). Epidemiconsetandoffsetweredeterminedatstate-level basedonthefirstandlastoftwoconsecutiveweekswhenthe weeklypercentageofpositivePCRtestsforRSVwasgreater thanorequalto3%.31Thisdefinitioniscommonlyusedby researchersandpublichealthagencies.Fromhereon,these weekswillbereferredtoastheclinicalonsetandoffsetand definedbythelastdayoftheweek.Itshouldbenotedthatthe datesofclinicalonsetandoffsetaredeterminedretrospectively afterthe2weeksof≥3%(FigureS3).Thedurationofthe epidemicwasdefinedasthenumberofweeksbetweenonset andoffset.WerecordedthemedianofRSV/PMMoVSduring theweeksofclinicalonsetandoffset,foreachstate. Thealgorithmfordeterminingdatesofwastewateronset andoffsetwasdevelopedindependently ofclinicaldataand wasinformedbyourpreviousworkobservingRSV concentrations inwastewater.21,32First,weusedthecriteria describedbyBoehmetal.toidentifyonsetandoffsetforeachTable1.Spearman’s RhoandPValuesforCorrelations Between State-aggregated Wastewater Concentrations andPositivity RateandHospitalization Ratea staterhobetweenWWand positivityratePvalueofrhobetweenWWand positivityraterhobetweenWWand hospitalization ratePvalueofrhobetweenWWand hospitalization rate N Alabama* 0.75 <0.001 49 Alaska* 0.51#0.164#9 Arkansas* NA NA 13 California 0.89 <0.001 0.90 <0.001 81 Colorado 0.8 <0.001 0.80 <0.001 62 Delaware* NA NA 24 Florida 0.81 <0.001 68 Georgia* 0.82 <0.001 0.86 <0.001 56 Hawaii* 0.09#0.783#11 Idaho 0.75 <0.001 73 Illinois 0.8 <0.001 51 Indiana 0.71 <0.001 49 Iowa* 0.93 <0.001 32 Kansas 0.81 <0.001 51 Kentucky 0.46 <0.001 73 Maine 0.8 <0.001 46 Maryland* 0.83 <0.001 0.93 <0.001 32 Massachusetts* 0.82 <0.001 32 Michigan 0.71 <0.001 0.89 <0.001 66 Minnesota* 0.26#0.0757#0.31 0.14#47 Nevada* 0.36#0.154#17 NewHampshire 0.77 <0.001 41 NewJersey 0.74 <0.001 50 NorthCarolina* 0.86 <0.001 48 Ohio* 0.8 <0.001 32 Pennsylvania* 0.8 <0.001 51 SouthDakota* NA NA 13 Tennessee* NA NA −0.5#0.66#6 Texas 0.42 <0.001 73 Utah 0.7 <0.001 0.93 <0.001 44 Vermont* 0.56#0.00968#20 Virginia* 0.3#0.0969#32 WestVirginia* NA NA 15 Wisconsin* NA NA 5 aHospitalization rateisonlyavailableforasmallsubsetofstateswithwastewaterdata,andablankcellindicatestherewasnohospitalization data availableforthatstate.NAindicatesthatarhocouldnotbecalculatedduetoalackofvariationinoneofthetwovariables.Nisthenumberofdata pointsusedinthecorrelations.Pvaluesgreaterthanorequalto0.001indicateanon-significant correlationandinthesecases,bothrhoandtheP valuearemarkedwitha#.AnasteriskappearsnexttoeachstateforwhichwastewaterdatawerenotavailablebeforethestateoftheRSVseasonas determinedbyclinicalpositivityratedata.ACSES&TWater pubs.acs.org/estwater Article https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−16671660Table2.Clinical andWastewater RSVOnset,Offset,andPeakin14Statesa state clinicalonset,offsetWWmedianat onset(×10−6)WWmedianat offset(×10−6) WWonset,offsetdateofpeak hosp.ratedateofpeak positivityratedateofpeak WW California 9/17/2022,2/4/2023 5.5 12.89/25/2022,4/6/2023 12/3/2022 11/12/2022 11/27/2022 Colorado 10/1/2022,2/18/2023 10.5 17.510/4/2022,4/9/2023 11/12/2022 11/19/2022 11/09/2022 Florida 5/7/2022,2/4/2023;7/22/2023,? 8.7 8.6 6/21/2022,7/10/2022;7/19/2022, 8/9/2022;8/19/2022, 1/31/202310/1/2022 6/11/2022 Idaho 10/29/2022,2/11/2023 8.3 47.310/29/2022,4/11/2023 11/26/2022 12/14/2022 Illinois 9/3/2022,12/24/2022 2.2 1.99/20/2022,4/25/2023 10/22/2022 10/30/2022 Indiana 8/27/2022,1/21/2023 8.0 3.09/27/2022,4/7/2023 10/15/2022 11/8/2022 Kansas 9/17/2022,1/21/2023 7.2 31.68/17/2022,3/15/2023 10/22/2022 12/2/2022 Kentucky 6/11/2022,6/25/2022;7/23/2022,7/30/2022;8/06/2022,1/7/2023 1.8 16.59/26/2022,2/21/2023 10/22/2022 11/15/2022 Maine 9/10/2022,3/4/2023 3.0 12.29/28/2022,4/10/2023 10/22/2022 11/12/2022 Michigan 9/10/2022,1/14/2023 2.0 92.28/20/2022,3/12/2023 11/12/2022 11/5/2022 11/17/2022 New Hampshire10/29/2022,2/4/2023 85 58.610/28/2022,3/17/2023 11/5/2022 12/13/2022 NewJersey9/17/2022,12/24/2022 4.6 71.410/13/2022,4/2/2023 11/5/2022 12/17/2022 Texas 4/30/2022,1/28/2023 1.6 13.6 6/2/2022,8/16/2022;9/7/2022, 3/5/202310/15/2022 12/10/2022 Utah 4/02/2022,4/23/2022;5/21/2022,6/11/2022;11/12/2022, 2/25/2023;4/08/2023,4/22/2023;6/17/2023,7/01/202327 7.910/26/2022,4/5/2023 11/26/2022 12/10/2022 12/4/2022 aForeachof14stateswithbothwastewaterandclinicaldataforthedurationofthe2022-2023RSVseason,weshowthedatesofclinicalonsetandoffset;iftherearemorethanone,theyareallgiven separatedbyasemicolonandaboldeddateistheoneusedforFigure3andinthetexttodescribethestartofRSVseason.TheweeklymedianRSV/PMMoVSduringtheMMWRweekofclinicalonset andoffsetisprovided;thevalueisunitless.“WWonset,offset”providesthedatesofwastewatereventonsetandoffset;ifmorethanoneoccurred,thenthedatesareseparatedbysemicolons.Thedateof onsetofthefirstwastewatereventisusedinFigure3andinthetext.Dateofthepeakvalueforhospitalization (hospitalization) rate,positivityrate,andwastewater(RSV/PMMoVS)areprovided.All datesaremonth/day/year format.The“?”intheFLclinicalonset/offsetcolumnindicatesthattheoffsetdateforthesecondonseteventinFLoccurredaftertheendofthisstudyandisunknown.ACSES&TWater pubs.acs.org/estwater Article https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−16671661individualWWTPasfollows.21ForeachindividualWWTP, thewastewateronsetdatewasidentifiedasthedateonwhich allsamplesina14daylookbackperiodhadmeasured concentrations ofRSVRNAthatexceededorwereequalto 2000cp/gdryweight.Thewastewateroffsetdatewas identifiedasthefirstdateafterwastewateronsetforwhich only50%ofsamplesduringa14daylookbackperiodhad concentrations overorequalto2,000cp/g.2000cp/gwas chosenasitrepresentsapproximately twotimesthedetection limit,asdescribedpreviously.21Wastewatereventonsetand offsetdateswereidentifiedfortheentirestateasfollows.The dateofwastewateronsetwasdeterminedasadatewhen50% ormoreoftheindividualWWTPsinthestatewereinonset,as describedabovefortheindividualplants,andoffsetasthedate afteronsetforwhichlessthan50%ofthesitesinthestatewere inonset.Forthisanalysis,anindividualplantwasnotgivenan onsetoroffsetdesignationforthefirst14daysofdata availability. Wecomparedepidemicpeaks,asdefinedbydiagnosticand hospitaldata,tothestate-aggregated peaksinRSVwastewater concentrations. Peaksofclinicaldataweredeterminedasthe weekwiththehighestvalues(lastdateofMMWRweek) whereaswastewaterpeakswereidentifiedasthedaywith highestvalueofRSV/PMMoV S. ■RESULTS QA/QC.Allwastewatermeasurements positiveandnegative controlswerepositiveandnegative,respectively,indicating acceptableassayperformanceandnocontamination acrossthe entirestudy.Median(IQR)BCoVrecoveriesacrossall sampleswere1.1(0.83,1.2),indicatinggoodrecoveryacrossthesamples.Recoveriesgreaterthan1arelikelyaresultof uncertaintiesinthemeasurementofBCoVaddedtothebuffer matrix.Additionaldetailsofreportingoutlinedinthe Environmental Microbiology MinimalInformation(EMMI) reportingguidelinesareprovidedelsewhere.27 RSVMeasurements andCorrelations withClinical RSVData.OverthestudyperiodofJanuary1,2022toJuly 31,2023,wastewaterdatawereavailablefrom176WWTPsin 34states(TableS1).Populationcoverageofthewastewater catchmentareasvariedfrom0.5to59.5%withamedian (interquartilerange,IQR)state-aggregated WWTPpopulation of324,045(119,000,693,000).RSVmeasurements individualWWTPsvariedfromnondetectto9.4×106cp/g dryweight(medianacrossallmeasurements was1.1×103cp/ g).TimeseriesplotsofRSVmeasurements fromallWWTPs areprovidedintheSupportingInformation(SI)(FigureS4). Wegenerallyfoundundetectablelevelsinthelatespringand summer,withpeakvaluesinthewinterinlinewithgeneral expectationsforseasonalityofRSVintheNorthernhemi- sphere.10 Wastewaterconcentrations paralleledclinicalsurveillance data.State-aggregated population-weighted averageRSV/ PMMoV(RSV/PMMoV S)wascalculatedforeachstatefor whichwastewaterdatawereavailable(N=34),and Spearman’srhowasdeterminedbetweenRSV/PMMoV Sand thestate-aggregated positivityrate.Rhoforsixstatescouldnot becalculatedbecauseavailablewastewatervalueswere constant;andrhowasnotstatisticallysignificantforfivestates (Table1).Thevastmajorityofthestatesforwhichrhowas notstatisticallysignificantorcouldnotbecalculatedhadRSV wastewaterdataavailableonlyafterlatespring/earlysummer Figure2.State-aggregated concentrations ofRSVRNA(RSVs,black/greyshadedarea,leftaxis)andpositivityrates(reddots,rightaxis).Red backgroundshadingindicatesperiodsbetweentheclinicalonsetandoffset.Blackfillbelowthewastewaterconcentrations indicatesperiodsofonset ofwastewaterevents,whereasgrayfillindicatestimeperiodswhenwastewatereventsarenotinonset.Thegrayfillisbarelyvisibleinmostpanels astheconcentrations priortoandafteronsetarelow.ACSES&TWater pubs.acs.org/estwater Article https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−16671662of2023,aftertheRSVseasonhadpassed(FiguresS2andS4, TableS1).Rhosfortheremainingstateswerestatistically significant(rhobetween0.42and0.93,p<0.001).Both wastewaterandhospitalization ratedatawereavailablefor8 states,andsorhowascalculatedtoassesstheirassociations (Table1).Rhovariedbetween0.80and0.93(p<0.001)for sixstates.Rhowasinsignificantfortheothertwostates (wastewaterdatacollectionstartedinJune2023,afterRSV season).NationallyaggregatedRSV/PMMoV (RSV/ PMMoVN)waspositivelyassociatedwithnationallyaggregated positivityandhospitalization rates(rho=0.73,p<0.001and rho=0.84,p<0.001,respectively). Onset,Offset,andPeakofRSVSeason.Wastewater datawereavailablebeforeclinicalonsetoftheRSVseasonin 14states(CA,CO,FL,ID,IL,IN,KS,KY,MI,ME,NH,NJ, UT,TX,Table2,FigureS2).Inthesestates,clinicalonsetof RSVseasonoccurredbetweenApril20,2022,andNovember 12,2022,andclinicaloffsetoccurredbetweenDecember24, 2022,andMarch4,2023,dependingonstate(Table2). DurationofRSVepidemicrangedfrom14to39weeksacross states;longerdurationwasgenerallyobservedinstateswith earlieronset.Most(11of14)stateshadoneRSVonsetduring thistimeperiod;FL,UT,andKYhadmultipleclinicalonset events(Figure2,Table2)wherepositivityratesincreasedover 3%fortwoconsecutiveweeksandthendecreasedagainbefore againmeetingtheonsetthreshold.Forthesethreestates,we consideredtheRSVseasonalclinicalonsetdatetobethat whichoccurredpriortothepeakinthepositivityrates. StateweeklymedianPMMoV-normalized wastewater concentrations (RSV/PMMoVS)duringtheweekofclinical onsetrangedfrom2.17 ×10−6to8.50 ×10−5,whilethe weeklymedianconcentrations duringtheweekofclinicaloffset rangedfrom1.88 ×10−6to9.22 ×10−5,dependingonthe state(Table2).Valuestendedtobehigherduringoffset comparedtoonset(one-sidedWilcoxonsignedranktest,p= 0.04,mediandifference=8.25 ×10−6). Forthe14states,thedateofwastewateronsetvaried betweenJune21toOctober29,2022,andthedateofoffset variedbetweenJanuary31andApril25,2023(Table2),with thedurationoftheeventbetween20and39weeks.Most(12 of14)ofthestatewastewaterdatashowedoneRSV wastewatereventoverthestudyperiod(Figure2,Table2). Twostates(FLandTX)hadmultipleRSVwastewaterevents. TXhadtwo,onebetweenearlyJuneandmidAugust2022, andtheotherbetweenearlySeptember2022andearlyMay2023.FLhadthreeRSVwastewaterevents:onebetweenlate Juneandmid-July2022,onebetweenlateJulyandearly August2022,andonebetweenmidAugustandlateJanuary 2023.ThedateusedfortheonsetofwastewaterforTXandFL wastheonsetdateofthefirstwastewaterevent. Forfourstates,wastewatereventonsetoccurredthesame weekasclinicalonset;forthreestates,wastewatereventonset occurred2to4weeksbeforeclinicalonset;andforseven states,wastewatereventonsetcommenced2to7weeksafter clinicalonset. Peaksinstate-aggregated populationweightedaverageRSV/ PMMoV(RSV/PMMoV S)acrossthe14statesrangedfrom October30toDecember17,2022,exceptforFLwherethe peakwasinmid-June(Table2).Peaksinhospitalization rates, forthe4of14stateswithavailablehospitalization ratedata, werewithinthesameweekasthepeakinwastewaterdata (Table2).Peaksinpositivityratedataweregenerallyearlier thanthepeaksinthewastewatervariable.Forthreestates(FL, CO,andUT),wastewaterpeaked1−16weeksearlierthanthe positivityratedata.Intheremaining11states,positivityrates peakedbeforewastewater(median3weeksearlier,range1−8 weeksearlier). The2022−2023RSVseasondemonstrated aconsistent geotemporalpatternofwastewateronset(Figure3).Waste- wateronsetoccurredearliestinthesouthinTexasandFlorida. Then,wastewateronsetmovednorthandwestalmost uniformly,withthemidwest(KansasandMichigan)first followedcloselybytheremainingstateswherewastewater onsetoccurrednearlyincoherence.Clinicalonsetfolloweda similarpatternwithclinicalonsetoccurringinTexasand Floridafirst,followedbyamoveofonsetbothwestandnorth. ■DISCUSSION RSVRNAconcentrations inwastewatercollectedthroughout theUnitedStatescorrelatetobothpositivityratesand hospitalizations nationallyandatthestatelevel,asshownfor singleorsmallgroupsofwastewatertreatmentplantsin previousstudies.15−17,19−21Sitesvariedfromurbantorural areas,spannedclimatesfromtropicaltocontinental,33and representedpopulationsservedfrom3000to4millionpersite withoverallcoverageof0.05to59.5%ofthestatepopulation. Despitesignificantdiversityinsitecharacteristics andcoverage fromstatetostate,correlationstoclinicalpositivityratesand hospitalizations werepositiveandsignificant.Hospitalization Figure3.Cumulativefractionof14states(y-axis)inRSVonset,asdeterminedbyclinicalpositivityratesinredandbywastewaterconcentrations inblack.Thedateofclinicalonset(red)orwastewatereventonset(black)isshownonthex-axis.Eachsymbolislabeledwiththestate.ACSES&TWater pubs.acs.org/estwater Article https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−16671663peakslargelymatchedwastewaterpeakstemporally,suggesting thevalueofwastewatermonitoringforinforminghospitalstaff andpublichealthnotifications. Forthefourstateswith sufficienthospitalization andwastewaterdata,thepeaksof bothwastewaterandhospitalizations allfellwithinan8day rangeofeachother. Despitethecoherencebetweenwastewaterandpositivity ratedata,thepeaksandonsetdeterminedusingthetwodata sourceswerenotalwaysaligned.Thelackofalignmentisa resultoftheinherentdifferencesandbiasesassociatedwiththe twodifferentsurveillanceapproaches.Thetwosurveillance sourcescaptureinformationaboutdifferentpopulations,those whoaresickandreceivetestingandthosewhoareshedding RSVRNA.Wastewaterconcentrations arecontrolledbyinputs tothesystemfromeveryindividualsheddingRSVRNA, includingthosewithsevereormildsymptomsandthosewho arebothsymptomatic andasymptomatic. Thereisno quantitativedataonlongitudinalRSVsheddinginhuman excretions,anditispossibleprolongedsheddingin convalescing orrecoveredindividualsoccurs.34Shedding magnitudeandduration,whileunknown,arekeydriversof wastewaterRSVconcentrations.35Thepositivityrateisnota measureofdiseaseincidenceorprevalencebutisoftenusedas aproxyfordiseaseoccurrence.Itmeasuresthefractionof individualswhoseekandobtainmedicalcareandforwhoma medicalprofessionalordersandadministersaRSVtestthat obtainsapositivetestresult.Theseindividualslikelysuffer fromsevereillnessorcomefromat-riskpopulations.Someof thesemayincludeinfantsindiaperswhoarelesslikelyto contributetowastewater.Therefore,thedifferencesinonset andpeaksinthetwomeasurescouldreflectdifferentpatterns ofincidentsymptomatic,moderatetosevereRSVofthosewith accesstomedicalcare(reflectedbythepositivityratedata), andcommunitylevelviralsheddingbyallthoseinfectedwith RSV(reflectedbythewastewaterdata). Analternateexplanationforthelackofagreementinpeaks andonsetaccordingtowastewaterandpositivityratedata streamsisthelimitationsandbiasesassociatedwitheach.The majorityofRSVinfectionsareunrecognized andarenot capturedbyclinicalsurveillancesystems.Inaprospective surveillancestudyofmorethan5000childrenintheU.S.with anacuterespiratoryinfection,only45%ofinpatientRSV infections�and amere3%ofoutpatientinfections�received thediagnosisRSV-associated illness.6Publiclyavailablestate- aggregatedpositivityratedatacanalsobeaffectedbythe numberoftestsadministered.Inourdataseries,somestates reportedasfewas1performedtestperweek,whichlimitsthe abilitytodetermineareliableestimateofthepositivityrate representingacommunity.Inaddition,clinicaltestingratesare nottemporallyuniformandtendtofluctuateaccordingtothe clinicallandscapeandclinicians’awarenessofongoingRSV circulation.Forexample,onthedateofclinicalonsetinIL,321 weeklytestswereperformed,whileonthedateofoffset,1370 weeklytestswereperformed.Additionally,publiclyavailable positivityratedatawasonlyavailableweekly,as3week averages,limitingtheresolutionatwhichchangesinpositivity ratescanbeidentified.Positivityratedataaregeneratedby clinicallaboratoriesparticipatinginNREVSS,whichisa passive,voluntaryprogram.Thenumberoflaboratories participatinginNREVSSvariesbystate(N=1to29per state),andtheexactlaboratoriescontributingpositivityrate dataatanytimearenotpubliclyavailableandmaychangeover time.36Similarly,thenumberofWWTPparticipatinginwastewatersurveillanceduringthestudyperioddifferedacross states(N=1to57perstate).Thespatialcoverageofthe participating laboratoriesreportingRSVtestresultsto NREVSSlikelydoesnotexactlymatchthespatialcoverage oftheWWTPinthestate(FigureS5),whichmeansthatthe twosurveillancemethodsarecapturingdistinctpopulations geographically aswell.Finally,theremaybefateprocessessuch asdecayandpartitioningthataffecttheconcentrations ofRSV asitmovesthroughthesewagenetworkbetweendrainand samplinglocationattheWWTPs;however,wehaveobserved verylimiteddecayofRSVRNAinwastewatersolidsoverthese timescales(unpublisheddata). ThealgorithmforidentifyingRSVseasononsetbasedon positivityratedataisonecommonlyused;31thealgorithmfor identifyingwastewateronsetwasdevelopedindependently thepositivityratedata.Thewastewateralgorithmrepresents anexampleapproachforidentifyingsignificantemergenceof RSVRNAinwastewater,butdifferentwastewatereventonset andoffsetthresholdsoralgorithmsthatarefitforspecific publichealthorotherstakeholderuse-casescanbedeveloped. Forexample,statisticalormachinelearningapproachescould beappliedtowastewaterandpositivityratedatatoderivean algorithmtopredicttheRSVclinicalonsetfromwastewater data.However,suchanapproachwouldrequireanassumption thatthepositivityratedatausedhereinrepresentthegold standardmetricsforRSVdiseaseoccurrence,wheninfact, theyhaveseriouslimitationsandbiases.ThePMMoV- normalizedRSVRNAconcentrations inwastewaterduring clinicalonsetandoffsetwereofasimilarmagnitudeacross statesandthecountry,suggestingthatasimpleconcentration thresholdcouldbeconsideredforidentifyingdatesofclinical onsetandoffsetusingwastewater. Wepositthatwastewatermeasurements ofRSVprovide importantinformationaboutpopulation-level RSVinfections, whichcanaugmenttraditionalRSVseasonindicatorslike hospitalization andpositivityrates.Wastewaterdataare availableinrealtime(assoonas24haftersamplecollection) andarenotsubjectedtodelaysassociatedwithclinicaldata reporting.15,37,38Inaddition,wastewatermeasurements arenot subjecttoanyclinicaltestingbiasestypicallypresentdueto socioeconomic factorsortestingavailability.38,39Importantly, wastewaterdatacanbeavailableatlocationswhereortimes whentraditionaldiseasemetricslikepositivityandhospital- izationratesarenotavailableofferingtheabilitytoprovide publichealthresourcesatappropriatespatialandtemporal scalesandprovidinginsightsintodiseaseepidemiology uniquelyavailablethroughwastewater. Limitations andRecommendations. Therearelimi- tationsassociatedwiththisstudy.Importantly,thetimingand spatialdistributionofwastewaterandclinicaldatadonot match.Moreover,RSVpositivityratesarebiasedby inconsistenttestseeking,availability,andreporting.Tomore preciselydeterminetherelationshipbetweenwastewaterand disease,studiesdesignedaprioriwillrequirebetter enumerationofinfectionsoccurringinwell-definedsewer- sheds.ExpandingclinicalRSVtestingwouldimproveRSV positivityratedataandpossiblymakeestimatesofRSV incidenceandprevalenceavailableatdifferentspatialand temporalresolutions.Untilthen,however,theclinicaldata usedhereinrepresentthebestavailablepubliclyaccessibleRSV data.Lackofcomplete,reliablepopulation-level clinicaldatais achallengeforawiderangeofimportantinfectiousdiseases thatarebeingstudiedusingwastewatersurveillance.40,41ACSES&TWater pubs.acs.org/estwater Article https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−16671664Scientistsinthefieldofwastewater-based epidemiology needtocontinuetodevelopcreativeapproachesforvalidating wastewaterdatawhenhigh-qualitypopulation-level clinical datadonotexist.Collaborations withinfectiousdisease scientiststocarryoutcoupledwastewater-disease surveillance studiesinsmallgeographicregionsmaybeonesolution. Additionally,weareunabletolinkaspecificwastewater concentration ofRSVtopopulation-level RSVincidenceor prevalencerates.Moreworkisneededtobetterunderstandthe sheddingofRSVinhumanexcretionstoprovidealinkage betweenwastewaterconcentrations anddiseaseoccurrencein thecontributingpopulation.Untilsuchdataareavailable,the dataprovidedhereinsuggestastrongrelationshipbetween RSVRNAinwastewatersolidsacrosstheUnitedStatesand moretraditionalRSVindicators.Futureworkcanuse wastewatertoexploretherelativeimportanceofRSVAand RSVB.42Whilemostclinicaltestsdonotdistinguishbetween thetwo,someevidencesuggeststheremaybedifferencesin diseaseseverityforthedifferentsubtypes.43 ■CONCLUSIONS Wastewaterconcentrations ofRSVRNAcancomplement traditionalclinicalindicatorsofdiseaseandinformpublic healthandclinicaldecisionmaking.RSVwastewater concentrations correlatewellwithtraditionaldiseasemetrics, suchaspositivityandhospitalization rates.OnsetdatesofRSV seasonderivedfromthepositivityrateandwastewaterdata sometimesagreedandsometimesdiffered;differencesare likelydrivenbythetwodatasourcessamplingdifferentgroups ofindividualswithdifferentillnessseverity.Peaksinwaste- waterandhospitalization ratesgenerallyoccurredatthesame time,whilepeaksinwastewaterandpositivityrateswerenot aligned,withwastewaterpeaksgenerallyoccurringafter positivityratepeaks.Wesuspectthatthedifferenceintiming ofpeaksiscontrolledbybothcomplexitiesassociatedwith magnitudeanddurationofRSVsheddingbyinfected individualsandbiasesandlimitationsassociatedwiththe positivityratedata.Thelackofcompleteagreementbetween thetwodatasourceshighlightstheadvantagesand disadvantages associatedwitheach. ■ASSOCIATED CONTENT +sıSupporting Information TheSupportingInformationisavailablefreeofchargeat https://pubs.acs.org/doi/10.1021/acsestwater.3c00725. Additionalmethodological detailsaswellasTablesS1 andS2andFiguresS1−S5(PDF) ■AUTHOR INFORMATION Corresponding Author Alexandria B.Boehm −DepartmentofCiviland EnvironmentalEngineering,StanfordUniversity,Stanford, California94305,UnitedStates; orcid.org/0000-0002- 8162-5090;Phone:650-724-9128; Email:aboehm@ stanford.edu Authors Alessandro Zulli −DepartmentofCivilandEnvironmental Engineering,StanfordUniversity,Stanford,California94305, UnitedStatesMeriR.J.Varkila −DivisionofInfectiousDiseasesand GeographicMedicine,DepartmentofMedicine,Stanford University,Stanford,California94305,UnitedStates JulieParsonnet −DivisionofInfectiousDiseasesand GeographicMedicine,DepartmentofMedicineand DepartmentofEpidemiologyandPopulationHealth, StanfordUniversity,Stanford,California94305,United States MarleneK.Wolfe −GangarosaDepartmentofEnvironmental Health,RollinsSchoolofPublicHealth,EmoryUniversity, Atlanta,Georgia30322,UnitedStates; orcid.org/0000- 0002-6476-0450 Completecontactinformationisavailableat: https://pubs.acs.org/10.1021/acsestwater.3c00725 AuthorContributions ⊥A.Z.,M.R.J.V.,andM.K.W.contributedequallytothiswork. CRediT: Alessandro Zulliconceptualization, datacuration, formalanalysis,investigation,methodology, validation,visual- ization,writing-original draft,writing-review &editing; Meri R.J.Varkilaconceptualization, datacuration,formalanalysis, investigation, methodology, validation,visualization,writing- originaldraft,writing-review &editing; JulieParsonnet conceptualization, fundingacquisition,supervision,writing- review&editing; Marlene KWolfeconceptualization, data curation,methodology, writing-original draft,writing-review & editing;Alexandria BBoehmconceptualization, datacuration, formalanalysis,fundingacquisition,investigation, method- ology,projectadministration, resources,supervision,valida- tion,visualization, writing-original draft,writing-review & editing. Funding ThisworkissupportedbygiftsfromtheCDCFoundationand theSergeyBrinFamilyFoundationtoABB.Thegraphical abstractwasmadeusingBioRender.com. Notes Theauthorsdeclarenocompetingfinancialinterest.■ACKNOWLEDGMENTS Weacknowledgethenumerouspeoplewhocontributedto wastewatersamplecollection.Graphicalabstractcreatedwith BioRender.com.■REFERENCES (1)Suh,M.;Movva,N.;Jiang,X.;Bylsma,L.C.;Reichert,H.; Fryzek,J.P.;Nelson,C.B.RespiratorySyncytialVirusIstheLeading CauseofUnitedStatesInfantHospitalizations, 2009−2019:AStudy oftheNational(Nationwide) InpatientSample.J.Infect.Dis.2022, 226(Supplement_2), S154−S163. (2)Li,Y.;Wang,X.;Blau,D.M.;Caballero,M.T.;Feikin,D.R.; Gill,C.J.;Madhi,S.A.;Omer,S.B.;Simo ̃es,E.A.F.;Campbell,H.; Pariente,A.B.;Bardach,D.;Bassat,Q.;Casalegno,J.-S.; Chakhunashvili, G.;Crawford,N.;Danilenko,D.;Do,L.A.H.; Echavarria,M.;Gentile,A.;Gordon,A.;Heikkinen,T.;Huang,Q.S.; Jullien,S.;Krishnan,A.;Lopez,E.L.;Markic ́,J.;Mira-Iglesias,A.; Moore,H.C.;Moyes,J.;Mwananyanda, L.;Nokes,D.J.;Noordeen, F.;Obodai,E.;Palani,N.;Romero,C.;Salimi,V.;Satav,A.;Seo,E.; Shchomak,Z.;Singleton,R.;Stolyarov,K.;Stoszek,S.K.;Von Gottberg,A.;Wurzel,D.;Yoshida,L.-M.;Yung,C.F.;Zar,H.J.;Nair, H.;Abram,M.;Aerssens,J.;Alafaci,A.;Balmaseda,A.;Bandeira,T.; Barr,I.;Batinovic ́,E.;Beutels,P.;Bhiman,J.;Blyth,C.C.;Bont,L.; Bressler,S.S.;Cohen,C.;Cohen,R.;Costa,A.-M.;Crow,R.;Daley, A.;Dang,D.-A.;Demont,C.;Desnoyers,C.;Díez-Domingo, J.; Divarathna,M.;DuPlessis,M.;Edgoose,M.;Ferolla,F.M.;Fischer,ACSES&TWater pubs.acs.org/estwater Article https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−16671665T.K.;Gebremedhin, A.;Giaquinto,C.;Gillet,Y.;Hernandez,R.; Horvat,C.;Javouhey,E.;Karseladze,I.;Kubale,J.;Kumar,R.;Lina, B.;Lucion,F.;MacGinty,R.;Martinon-Torres, F.;McMinn,A.; Meijer,A.;Milic ́,P.;Morel,A.;Mulholland,K.;Mungun,T.; Murunga,N.;Newbern,C.;Nicol,M.P.;Odoom,J.K.;Openshaw, P.;Ploin,D.;Polack,F.P.;Pollard,A.J.;Prasad,N.;Puig-Barbera ̀,J.; Reiche,J.;Reyes,N.;Rizkalla,B.;Satao,S.;Shi,T.;Sistla,S.;Snape, M.;Song,Y.;Soto,G.;Tavakoli,F.;Toizumi,M.;Tsedenbal,N.;Van DenBerge,M.;Vernhes,C.;VonMollendorf,C.;Walaza,S.;Walker, G.Global,Regional,andNationalDiseaseBurdenEstimatesofAcute LowerRespiratoryInfectionsDuetoRespiratorySyncytialVirusin ChildrenYoungerthan5Yearsin2019:ASystematicAnalysis.Lancet 2022,399(10340),2047−2064. (3)O’Brien,K.L.;Baggett,H.C.;Brooks,W.A.;Feikin,D.R.; Hammitt,L.L.;Higdon,M.M.;Howie,S.R.C.;Knoll,M.D.; Kotloff,K.L.;Levine,O.S.;Madhi,S.A.;Murdoch,D.R.;Prosperi, C.;Scott,J.A.G.;Shi,Q.;Thea,D.M.;Wu,Z.;Zeger,S.L.;Adrian, P.V.;Akarasewi,P.;Anderson,T.P.;Antonio,M.;Awori,J.O.; Baillie,V.L.;Bunthi,C.;Chipeta,J.;Chisti,M.J.;Crawley,J.; DeLuca,A.N.;Driscoll,A.J.;Ebruke,B.E.;Endtz,H.P.;Fancourt, N.;Fu,W.;Goswami,D.;Groome,M.J.;Haddix,M.;Hossain,L.; Jahan,Y.;Kagucia,E.W.;Kamau,A.;Karron,R.A.;Kazungu,S.; Kourouma,N.;Kuwanda,L.;Kwenda,G.;Li,M.;Machuka,E.M.; Mackenzie,G.;Mahomed,N.;Maloney,S.A.;McLellan,J.L.; Mitchell,J.L.;Moore,D.P.;Morpeth,S.C.;Mudau,A.; Mwananyanda, L.;Mwansa,J.;Ominde,M.S.;Onwuchekwa, U.; Park,D.E.;Rhodes,J.;Sawatwong,P.;Seidenberg,P.;Shamsul,A.; Simo ̃es,E.A.F.;Sissoko,S.;Somwe,S.W.;Sow,S.O.;Sylla,M.; Tamboura,B.;Tapia,M.D.;Thamthitiwat, S.;Toure,A.;Watson,N. L.;Zaman,K.;Zaman,S.M.A.CausesofSeverePneumonia RequiringHospitalAdmissioninChildrenwithoutHIVInfection fromAfricaandAsia:ThePERCHMulti-Country Case-Control Study.Lancet2019,394(10200),757−779. (4)Thompson,W.W.;Shay,D.K.;Weintraub,E.;Brammer,L.; Cox,N.;Anderson,L.J.;Fukuda,K.MortalityAssociatedwith InfluenzaandRespiratorySyncytialVirusintheUnitedStates.JAMA 2003,289(2),179−186. (5)Hansen,C.L.;Chaves,S.S.;Demont,C.;Viboud,C.Mortality AssociatedWithInfluenzaandRespiratorySyncytialVirusintheUS, 1999−2018.JAMANetworkOpen2022,5(2),No.e220527. (6)Hall,C.B.;Weinberg,G.A.;Iwane,M.K.;Blumkin,A.K.; Edwards,K.M.;Staat,M.A.;Auinger,P.;Griffin,M.R.;Poehling,K. A.;Erdman,D.;Grijalva,C.G.;Zhu,Y.;Szilagyi,P.TheBurdenof RespiratorySyncytialVirusInfectioninYoungChildren.NewEngland JournalofMedicine 2009,360(6),588−598. (7)Glezen,W.P.;Taber,L.H.;Frank,A.L.;Kasel,J.A.Riskof PrimaryInfectionandReinfectionWithRespiratorySyncytialVirus. AmericanJournalofDiseasesofChildren 1986,140(6),543−546. (8)Nakajo,K.;Nishiura,H.Age-Dependent RiskofRespiratory SyncytialVirusInfection:ASystematicReviewandHazardModeling fromSerologicalData.J.Infect.Dis.2023,228,1400. (9)Surie,D.DiseaseSeverityofRespiratorySyncytialVirus ComparedwithCOVID-19andInfluenzaAmongHospitalized AdultsAged ≥60Years �IVYNetwork,20U.S.States,February 2022−May2023.Morb.Mortal.Wkly.Rep.2023,72,1083 DOI:10.15585/mmwr.mm7240a2. (10)Obando-Pacheco, P.;Justicia-Grande, A.J.;Rivero-Calle,I.; Rodríguez-Tenreiro, C.;Sly,P.;Ramilo,O.;Mejías,A.;Baraldi,E.; Papadopoulos, N.G.;Nair,H.;Nunes,M.C.;Kragten-Tabatabaie, L.; Heikkinen,T.;Greenough,A.;Stein,R.T.;Manzoni,P.;Bont,L.; Martinón-Torres, F.RespiratorySyncytialVirusSeasonality:AGlobal Overview.JournalofInfectiousDiseases 2018,217(9),1356−1364. (11)RSVSurveillanceandResearch |CDC.https://www.cdc.gov/ rsv/research/index.html. (12)Hamid,S.;Winn,A.;Parikh,R.;Jones,J.M.;McMorrow,M.; Prill,M.M.;Silk,B.J.;Scobie,H.M.;Hall,A.J.Seasonalityof RespiratorySyncytialVirus �UnitedStates,2017−2023.MMWR MorbMortalWklyRep2023,72(14),355−361.(13)Stein,R.T.;Zar,H.J.RSVthroughtheCOVID-19Pandemic: Burden,ShiftingEpidemiology, andImplicationsfortheFuture. PediatricPulmonology 2023,58(6),1631−1639. (14)Toribio-Avedillo, D.;Gómez-Gómez, C.;Sala-Comorera, L.; Rodríguez-Rubio, L.;Carcereny,A.;García-Pedemonte, D.;Pintó,R. M.;Guix,S.;Galofré,B.;Bosch,A.;Merino,S.;Muniesa,M. MonitoringInfluenzaandRespiratorySyncytialVirusinWastewater. BeyondCOVID-19.ScienceofTheTotalEnvironment 2023,892, No.164495. (15)Hughes,B.;Duong,D.;White,B.J.;Wigginton,K.R.;Chan,E. M.G.;Wolfe,M.K.;Boehm,A.B.RespiratorySyncytialVirus(RSV) RNAinWastewaterSettledSolidsReflectsRSVClinicalPositivity Rates.Environ.Sci.Technol.Lett.2022,9(2),173−178. (16)Boehm,A.B.;Hughes,B.;Doung,D.;Chan-Herur,V.; Buchman,A.;Wolfe,M.K.;White,B.J.WastewaterSurveillanceof HumanInfluenza,Metapneumovirus, Parainfluenza, Respiratory SyncytialVirus(RSV),Rhinovirus,andSeasonalCoronaviruses duringtheCOVID-19Pandemic;preprint;InfectiousDiseases (exceptHIV/AIDS), medRxiv2022.DOI:10.1101/ 2022.09.22.22280218. (17)Koureas,M.;Mellou,K.;Vontas,A.;Kyritsi,M.;Panagoulias, I.;Koutsolioutsou, A.;Mouchtouri,V.A.;Speletas,M.;Paraskevis,D.; Hadjichristodoulou, C.WastewaterLevelsofRespiratorySyncytial VirusAssociatedwithInfluenza-like IllnessRatesinChildren�A CaseStudyinLarissa,Greece(October2022−January 2023). InternationalJournalofEnvironmentalResearchandPublicHealth 2023,20(6),5219. (18)Hayes,E.K.;Gouthro,M.T.;LeBlanc,J.J.;Gagnon,G.A. Simultaneous DetectionofSARS-CoV-2, InfluenzaA,Respiratory SyncytialVirus,andMeaslesinWastewaterbyMultiplexRT-qPCR. ScienceofTheTotalEnvironment 2023,889,No.164261. (19)Mercier,E.;Pisharody,L.;Guy,F.;Wan,S.;Hegazy,N.; D’Aoust,P.M.;Kabir,M.P.;Nguyen,T.B.;Eid,W.;Harvey,B.; Rodenburg,E.;Rutherford,C.;Mackenzie,A.E.;Willmore,J.;Hui, C.;Paes,B.;Delatolla,R.;Thampi,N.Wastewater-Based Surveillance IdentifiesStarttothePediatricRespiratorySyncytialVirusSeasonin TwoCitiesinOntario,Canada.FrontPublicHealth2023,11, 1261165. (20)Ahmed,W.;Bivins,A.;Stephens,M.;Metcalfe,S.;Smith,W.J. M.;Sirikanchana, K.;Kitajima,M.;Simpson,S.L.Occurrenceof MultipleRespiratoryVirusesinWastewaterinQueensland,Australia: PotentialforCommunityDiseaseSurveillance.ScienceofTheTotal Environment 2023,864,No.161023. (21)Boehm,A.B.;Wolfe,M.K.;White,B.J.;Hughes,B.;Duong, D.;Bidwell,A.MorethanaTripledemic: InfluenzaAVirus, RespiratorySyncytialVirus,SARS-CoV-2, andHumanMetapneu- movirusinWastewaterduringWinter2022−2023.Environ.Sci. Technol.Lett.2023,10(8),622−627. (22)Schoen,M.E.;Bidwell,A.L.;Wolfe,M.K.;Boehm,A.B. UnitedStatesInfluenza2022−2023SeasonCharacteristics asInferred fromWastewaterSolids,InfluenzaHospitalization, andSyndromic Data.Environ.Sci.Technol. 2023,57(49),20542−20550. (23)RSVSurveillanceData-NREVSS |CDC.https://www.cdc.gov/ surveillance/nrevss/rsv/index.html. (24)RSV-NET:RespiratorySyncytialVirusHospitalizationSurveil- lanceNetwork,InteractiveDashboard |CDC.https://www.cdc.gov/ rsv/research/rsv-net/dashboard.html. (25)Simpson,A.;Topol,A.;White,B.J.;Wolfe,M.K.;Wigginton, K.R.;Boehm,A.B.EffectofStorageConditionsonSARS-CoV-2 RNAQuantification inWastewaterSolids.PeerJ.2021,9,No.e11933. (26)Roldan-Hernandez, L.;Boehm,A.B.AdsorptionofRespiratory SyncytialVirus,Rhinovirus,SARS-CoV-2,andF+Bacteriophage MS2 RNAontoWastewaterSolidsfromRawWastewater.Environ.Sci. Technol. 2023,57(36),13346−13355. (27)Boehm,A.;Wolfe,M.;Wigginton,K.;Bidwell,A.;White,B.; Duong,D.;Hughes,B.;Chan-Herur,V.;Naughton,C.;Bischel,H. HumanViralNucleicAcidsConcentrationsinWastewaterSolidsfrom CentralandCoastalCalifornia,BoehmResearchGroupatStanford: USA,2023.DOI:10.25740/cx529np1130.ACSES&TWater pubs.acs.org/estwater Article https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−16671666(28)Topol,A.;Wolfe,M.;Wigginton,K.;White,B.J.;Boehm,B.A. HighThroughputRNAExtractionandPCRInhibitorRemovalofSettled SolidsforWastewaterSurveillanceofSARS-CoV-2RNAV.22021. (29)McClary-Gutierrez, J.S.;Aanderud,Z.T.;Al-faliti,M.; Duvallet,C.;Gonzalez,R.;Guzman,J.;Holm,R.H.;Jahne,M.A.; Kantor,R.S.;Katsivelis,P.;Kuhn,K.G.;Langan,L.M.;Mansfeldt, C.;McLellan,S.L.;Grijalva,L.M.M.;Murnane,K.S.;Naughton,C. C.;Packman,A.I.;Paraskevopoulos, S.;Radniecki,T.S.;Roman,F. A.;Shrestha,A.;Stadler,L.B.;Steele,J.A.;Swalla,B.M.;Vikesland, P.;Wartell,B.;Wilusz,C.J.;Wong,J.C.C.;Boehm,A.B.;Halden,R. U.;Bibby,K.;Vela,J.D.Standardizing DataReportinginthe ResearchCommunitytoEnhancetheUtilityofOpenDataforSARS- CoV-2WastewaterSurveillance.Environ.Sci.:WaterRes.Technol. 2021,7(9),1545−1551. (30)Symonds,E.M.;Nguyen,K.H.;Harwood,V.J.;Breitbart,M. PepperMildMottleVirus:APlantPathogenwithaGreaterPurpose in(Waste)Water TreatmentDevelopment andPublicHealth Management.WaterRes.2018,144,1−12. (31)Midgley,C.M.;Haynes,A.K.;Baumgardner, J.L.; Chommanard, C.;Demas,S.W.;Prill,M.M.;Abedi,G.R.;Curns, A.T.;Watson,J.T.;Gerber,S.I.DeterminingtheSeasonalityof RespiratorySyncytialVirusintheUnitedStates:TheImpactof IncreasedMolecularTesting.J.InfectDis2017,216(3),345−355. (32)Boehm,A.B.;Wolfe,M.K.;Wigginton,K.R.;Bidwell,A.; White,B.J.;Hughes,B.;Duong,D.;Chan-Herur,V.;Bischel,H.N.; Naughton,C.C.HumanViralNucleicAcidsConcentrations WastewaterSolidsfromCentralandCoastalCaliforniaUSA.Sci.Data 2023,10,396. (33)Beck,H.E.;Zimmermann, N.E.;McVicar,T.R.;Vergopolan, N.;Berg,A.;Wood,E.F.PresentandFutureKöppen-GeigerClimate Classification Mapsat1-KmResolution.Sci.Data2018,5(1), No.180214. (34)Lowry,S.A.;Wolfe,M.K.;Boehm,A.B.RespiratoryVirus Concentrations inHumanExcretionsThatContributetoWastewater: ASystematicReviewandMeta-Analysis.JournalofWaterandHealth 2023,21(6),831−848. (35)Arts,P.J.;Kelly,J.D.;Midgley,C.M.;Anglin,K.;Lu,S.; Abedi,G.R.;Andino,R.;Bakker,K.M.;Banman,B.;Boehm,A.B.; Briggs-Hagen, M.;Brouwer,A.F.;Davidson,M.C.;Eisenberg,M.C.; Garcia-Knight, M.;Knight,S.;Peluso,M.J.;Pineda-Ramirez, J.; Sanchez,R.D.;Saydah,S.;Tassetto,M.;Martin,J.N.;Wigginton,K. R.LongitudinalandQuantitativeFecalSheddingDynamicsofSARS- CoV-2,PepperMildMottleVirus,andcrAssphage.mSphere 2023, e0013223. (36)ListofParticipatingNREVSSLabs |CDC.https://www.cdc. gov/surveillance/nrevss/labs/list.html. (37)NorovirusNationalTrends-NREVSS |CDC.https://www.cdc. gov/surveillance/nrevss/norovirus/natl-trend.html. (38)Boehm,A.B.;Wolfe,M.K.;White,B.J.;Hughes,B.;Duong, D.DivergenceofWastewaterSARS-CoV-2andReportedLaboratory- ConfirmedCOVID-19IncidentCaseDataCoincidentwithWide- SpreadAvailabilityofat-HomeCOVID-19AntigenTests.PeerJ2023, e15631DOI:10.7717/peerj.15631. (39)Kaplan,E.H.;Wang,D.;Wang,M.;Malik,A.A.;Zulli,A.; Peccia,J.AligningSARS-CoV-2IndicatorsviaanEpidemicModel: ApplicationtoHospitalAdmissionsandRNADetectioninSewage Sludge.HealthCareManage.Sci.2021,24,320. (40)Wolfe,M.K.;Paulos,A.H.;Zulli,A.;Duong,D.;Shelden,B.; White,B.J.;Boehm,A.B.WastewaterDetectionofEmerging ArbovirusInfections:CaseStudyofDengueintheUnitedStates. Environ.Sci.Technol.Lett.2024,11(1),9−15. (41)Barber,C.;Crank,K.;Papp,K.;Innes,G.K.;Schmitz,B.W.; Chavez,J.;Rossi,A.;Gerrity,D.Community-Scale Wastewater SurveillanceofCandidaAurisduringanOngoingOutbreakin SouthernNevada.Environ.Sci.Technol. 2023,57(4),1755−1763. (42)Boehm,A.B.;Hughes,B.;Duong,D.;Chan-Herur,V.; Buchman,A.;Wolfe,M.K.;White,B.J.WastewaterConcentrations ofHumanInfluenza,Metapneumovirus, Parainfluenza, Respiratory SyncytialVirus,Rhinovirus,andSeasonalCoronavirusNucleic-AcidsduringtheCOVID-19Pandemic:ASurveillanceStudy.Lancet Microbe 2023,4(5),e340DOI:10.1016/S2666-5247(22)00386-X. (43)Vandini,S.;Biagi,C.;Lanari,M.RespiratorySyncytialVirus: TheInfluenceofSerotypeandGenotypeVariabilityonClinical CourseofInfection.Int.J.Mol.Sci.2017,18(8),1717.ACSES&TWater pubs.acs.org/estwater Article https://doi.org/10.1021/acsestwater.3c00725 ACSESTWater2024,4,1657−16671667
